<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several papers have recorded that Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> can protect B-cells from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present paper, we record an increase in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in an EBV-infected human Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line (AW-Ramos), compared with its virus free counterpart (Ramos) </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mp ids='MP_0001799'>viral</z:mp>-infected cells died more rapidly by <z:mpath ids='MPATH_3'>apoptosis</z:mpath> during <z:mpath ids='MPATH_458'>normal</z:mpath> growth in culture: at 72h, Ramos cells had 8% <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and AW-Ramos had 27% <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>The EBV-infected cells were particularly sensitive to treatment with <z:chebi fb="0" ids="8116">phorbol</z:chebi>-12, 13-dibutyrate (<z:chebi fb="0" ids="17598">PDBu</z:chebi>, 0.05 microgram/ml): at 72h, Ramos cells had 12% <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and AW-Ramos had 42% <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>DNA gel electrophoresis supported the morphological findings </plain></SENT>
<SENT sid="5" pm="."><plain>Our results serve as a caveat against generalizations that may be made about prevention of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
</text></document>